PA
ECVT icon

PharVision Advisers’s Ecovyst ECVT Stock Holding History

PharVision Advisers’s Portfolio ECVT Stock Details ECVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,580
Closed -$101K – 769
2025
Q3 		$101K Buy
+11,580
New +$102K 0.06% 622
2025
Q1 		– Sell
-58,121
Closed -$444K – 338
2024
Q4 		$444K Buy
+58,121
New +$429K 0.38% 60

Other funds holding ECVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PharVision Advisers's ECVT Position: Q4 2025 in Review

PharVision Advisers sold out of Ecovyst (ECVT) in Q4 2025, closing a stake of 11,580 shares — an estimated $101K sold.

PharVision Advisers first reported a position in ECVT in Q4 2024 and held it in 2 quarters. The position peaked at $444K in Q4 2024. 161 funds tracked by Wall St. Rank hold ECVT as of Q4 2025.

  • PharVision Advisers reported no remaining Ecovyst position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 11,580 Ecovyst shares in Q4 2025, an estimated $101K.
  • PharVision Advisers first reported a position in Ecovyst in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Ecovyst position peaked at $444K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Ecovyst as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.